| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BIOA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 976.9K | $17.70M | - | |
| CFO | 36.6K | $160.2K | - | |
| Other | 0 | - | - | |
| Other | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Pande Vijay Satyanand | Director | Buy | 900,000 | $18.00 | $16,200,000.00 | New | -72.0% | -74.2% | |
| Sep 27, 2024 | Barton Shane | Principal Accounting Officer | Buy | 2,632 | $18.00 | $47,376.00 | New | -72.0% | -74.2% | |
| Sep 27, 2024 | Cormorant Asset Management, LP49 | - | Buy | 450,000 | $18.00 | $8,100,000.00 | +38.2% | -72.0% | -74.2% | |
| Sep 27, 2024 | Healy James | Director | Buy | 666,665 | $18.00 | $11,999,970.00 | -104.1% | -72.0% | -74.2% | |
| Sep 27, 2024 | Enright Patrick G75 | Director | Buy | 400,000 | $18.00 | $7,200,000.00 | +30.5% | -72.0% | -74.2% |